ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Principia Biopharma Inc

Principia Biopharma Inc (PRNB)

100.05
0.00
(0.00%)
終値: 11月13日 6:00AM
100.05
0.00
( 0.00% )
取引時間後: -

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
100.05
買値
99.65
売値
100.05
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
100.05
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

PRNB 最新ニュース

Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib

SOUTH SAN FRANCISCO, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc., a Sanofi company, focused on developing treatments for immune mediated diseases, today announced it has...

Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related Disease

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune...

Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of Directors

SEATTLE, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de...

Sanofi to acquire Principia Biopharma

Sanofi to acquire Principia Biopharma * Further strengthens core R&D areas of autoimmune and allergic diseases * Provides full control of brain-penetrant BTK inhibitor SAR442168 in multiple...

Principia Biopharma Reports Second Quarter 2020 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune...

Principia Announces First Patient Enrolled in Sanofi’s Phase 3 Trial of SAR442168 in Relapsing Multiple Sclerosis

SOUTH SAN FRANCISCO, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for...

Principia Announces Positive Data from its Phase 2 Part B Trial in Pemphigus

Clear dose-response combined with decreased daily corticosteroid usage Response rate increased with extended duration of treatment to six months while maintaining a favorable safety profile SOUTH...

Principia Presents Updated Positive Data of Rilzabrutinib for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial

Oral BTK inhibitor reaches primary endpoint in 50 percent of patients treated > 12 weeks; demonstrates fast onset and durable responses Principia to initiate pivotal Phase 3 trial in ITP SOUTH...

Principia Biopharma to Hold Virtual Analyst Event to Discuss BTK Inhibition: Beyond B Cells and Antibodies

SOUTH SAN FRANCISCO, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for...

Principia Announces Data Presentations of Rilzabrutinib in Patients with Immune Thrombocytopenia (ITP) at Two Upcoming Virtua...

SOUTH SAN FRANCISCO, Calif., May 26, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CYCCCyclacel Pharmaceuticals Inc
US$ 0.5777
(40.90%)
1.71M
ONMDOneMedNet Corporation
US$ 1.18
(24.21%)
4.87M
MULNMullen Automotive Inc
US$ 3.70
(24.16%)
6.21M
RKLBRocket Lab USA Inc
US$ 17.89
(22.03%)
5.66M
MVSTMicrovast Holdings Inc
US$ 0.2136
(18.21%)
470.57k
SYRSSyros Pharmaceuticals Inc
US$ 0.19
(-93.04%)
1.94M
VRMVroom Inc
US$ 5.77
(-34.95%)
31.07k
INSGInseego Corporation
US$ 13.45
(-25.94%)
29.21k
VINOGaucho Group Holdings Inc
US$ 3.60
(-19.10%)
7.42k
NANano Labs Ltd
US$ 6.23
(-19.09%)
292.07k
JGLOJP Morgan Global Select Equity ETF
US$ 63.13
(0.00%)
18.88M
SOUNSoundHound AI Inc
US$ 7.37
(-2.51%)
9.22M
MULNMullen Automotive Inc
US$ 3.70
(24.16%)
6.21M
LGMKLogicMark Inc
US$ 0.1829
(2.46%)
6.02M
RKLBRocket Lab USA Inc
US$ 17.89
(22.03%)
5.66M

最近閲覧した銘柄

Delayed Upgrade Clock